Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Healthtrust
Citi
Baxter
Teva
Federal Trade Commission
Cerilliant
Covington

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087739

« Back to Dashboard

NDA 087739 describes UROVIST MEGLUMINE DIU/CT, which is a drug marketed by Bayer Hlthcare and is included in one NDA. Additional details are available on the UROVIST MEGLUMINE DIU/CT profile page.

The generic ingredient in UROVIST MEGLUMINE DIU/CT is diatrizoate meglumine. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diatrizoate meglumine profile page.
Summary for 087739
Tradename:UROVIST MEGLUMINE DIU/CT
Applicant:Bayer Hlthcare
Ingredient:diatrizoate meglumine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 087739

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength30%
Approval Date:Sep 23, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Deloitte
Healthtrust
US Army
Johnson and Johnson
Dow
Argus Health
UBS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.